NCT03054922

Brief Summary

During major surgical procedures, intravascular volume is maintained with the administration of isotonic fluids such as Lactated Ringers (LR), Normal Saline (NS) or Normosol-R. All three of these fluids are in common clinical use for this purpose. As large volumes of NS may result in a dilutional acidosis and an increasing base deficit, it may cloud clinical decision making when resuscitative efforts are guided by acid-base status on routine arterial blood gas analysis. This is a prospective, randomized study to evaluate changes in acid-base and electrolyte (sodium, potassium, calcium) status with the use of various isotonic fluids for intraoperative resuscitation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Feb 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 13, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 16, 2017

Completed
7 days until next milestone

Study Start

First participant enrolled

February 23, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2018

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

March 25, 2020

Completed
Last Updated

March 25, 2020

Status Verified

March 1, 2020

Enrollment Period

1.6 years

First QC Date

February 13, 2017

Results QC Date

March 11, 2020

Last Update Submit

March 11, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Base Deficit

    Change in base deficit from 1st to 2nd blood gas to measure metabolic acidosis

    During surgery (typically 4-6 hrs in length)

Secondary Outcomes (4)

  • Change in Sodium

    During surgery (typically 4-6 hrs in length)

  • Change in Potassium

    During surgery (typically 4-6 hrs in length)

  • Change in Ionized Calcium

    During surgery (typically 4-6 hrs in length)

  • Change in pH

    During surgery (typically 4-6 hrs in length)

Study Arms (3)

Normal Saline

ACTIVE COMPARATOR

0.9% Sodium Chloride

Drug: Normal Saline

Lactated Ringers

ACTIVE COMPARATOR

Each 100 mL of Lactated Ringer's Injection USP contains: Sodium Chloride USP 0.6 g; Sodium Lactate USP 0.31 g; Potassium Chloride USP 0.03 g; Calcium Chloride Dihydrate USP 0.02 g; Water for Injection USP qs

Drug: Lactated Ringer

Normosol-R

ACTIVE COMPARATOR

Each 100 mL of Normosol-R contains sodium chloride, 526 mg; sodium acetate, 222 mg; sodium gluconate, 502 mg; potassium chloride, 37 mg; magnesium chloride hexahydrate, 30 mg.

Drug: Normosol-R Inj

Interventions

IV infusion of 0.9% NaCl throughout surgery.

Also known as: 0.9% NaCl
Normal Saline

IV infusion of lactated ringer throughout surgery.

Lactated Ringers

IV infusion of Normosol throughout surgery.

Normosol-R

Eligibility Criteria

Age10 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Major surgical procedure requiring arterial access

You may not qualify if:

  • Comorbid disease process that contraindicates the use of any 1 of the 3 crystalloid solutions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

Location

MeSH Terms

Interventions

Saline SolutionRinger's Lactate

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Results Point of Contact

Title
David P. Martin, MD
Organization
Nationwide Children's Hospital

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Acute Pain Services

Study Record Dates

First Submitted

February 13, 2017

First Posted

February 16, 2017

Study Start

February 23, 2017

Primary Completion

September 30, 2018

Study Completion

September 30, 2018

Last Updated

March 25, 2020

Results First Posted

March 25, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations